• Successfully listed in Hong Kong stock exchange together with China Isotope & Radiation Corporation as a whole. (Stock code: 01763.HK)
  • Being selected as one of the G20 enterprises in “Beijing Biomedical Industry Leap-Forward Development Project (G20 Project)”.
  • Being selected as one of the key enterprises in the “Ten-Hundred-Thousand” Project in Zhongguancun National Independent Innovation Demonstration Zone.
  • The controlling shareholder had been shifted from China Institute of Atomic Energy (CIAE) to China Isotope & Radiation Corporation (CIRC).
  • HTA was identified as a high-tech enterprise, and successfully passed the re-identification in October 2011, November 2014 and August 2017.
  • Successfully listed on the National Equities Exchange and Quotations, becoming the first listed company in the NEEQ among the nuclear technology application system in China National Nuclear Corporation (CNNC).
  • HTA completed capital increase and share expansion.